Characteristics of Tumor Extension Requiring Bronchoplasty and Pneumonectomy in Patients with Lung Cancer and Positive Bronchoscopic Findings

Surgery Today ◽  
2006 ◽  
Vol 36 (6) ◽  
pp. 491-498 ◽  
Author(s):  
Yasuo Sekine ◽  
Yukio Saitoh ◽  
Masako Chiyo ◽  
Kazuhiro Yasufuku ◽  
Akira Iyoda ◽  
...  
Keyword(s):  
2021 ◽  
Vol 161 ◽  
pp. S331-S332
Author(s):  
M. Schmitt ◽  
L. Aussenac ◽  
J. Seitlinger ◽  
V. Lindner ◽  
G. Noël ◽  
...  

Author(s):  
Claire Meynard ◽  
Audrey Mansuet-Lupo ◽  
Nicolas Giraud ◽  
Geoffroy Boulle ◽  
Paul Imbault ◽  
...  

2009 ◽  
Vol 8 (1) ◽  
pp. 79-84 ◽  
Author(s):  
Bojan Zaric ◽  
Vukasin Canak ◽  
Goran Stojanovic ◽  
Aleksandra Jovelic ◽  
Tatjana Sarcev ◽  
...  
Keyword(s):  

2017 ◽  
Vol 23 (4) ◽  
pp. 180-183
Author(s):  
Elena Dantes ◽  
Doina Ecaterina Tofolean ◽  
Ariadna Petronela Fildan ◽  
Laura Mazilu ◽  
Ioana Gogonea ◽  
...  

AbstractLung cancer remains one of the most frequent pathologies in Pulmonology Departments. Tumor extension, histopathological types, and treatment influence the prognosis and survival in lung cancer. Five years survival dramatically decreases for the 4th-stage of the disease. Non-small cell lung cancer (NSCLC) represents the vast majority of lung cancers. In the last decades, important findings have been made on identifying standardized molecular biomarkers that control tumor growth in lung adenocarcinoma. The discovery of new drugs led to the increased survival, even in extensive forms of the disease. The greatest advances could be obtained by targeting EGFR genetic mutations or EML4-ALK translocate in patients diagnosed with adenocarcinoma lung cancer


Lung Cancer ◽  
1994 ◽  
Vol 11 ◽  
pp. 23
Author(s):  
J.P. Kleisbauer ◽  
P. Thomas ◽  
J. Vion-Dury ◽  
M. Sciaky ◽  
S. Confort-Gouny ◽  
...  

JAMA ◽  
1966 ◽  
Vol 195 (12) ◽  
pp. 1036-1037 ◽  
Author(s):  
P. Rubin
Keyword(s):  

JAMA ◽  
1966 ◽  
Vol 195 (6) ◽  
pp. 471-475 ◽  
Author(s):  
M. J. Krant

2016 ◽  
Vol 1 (13) ◽  
pp. 162-168
Author(s):  
Pippa Hales ◽  
Corinne Mossey-Gaston

Lung cancer is one of the most commonly diagnosed cancers across Northern America and Europe. Treatment options offered are dependent on the type of cancer, the location of the tumor, the staging, and the overall health of the person. When surgery for lung cancer is offered, difficulty swallowing is a potential complication that can have several influencing factors. Surgical interaction with the recurrent laryngeal nerve (RLN) can lead to unilateral vocal cord palsy, altering swallow function and safety. Understanding whether the RLN has been preserved, damaged, or sacrificed is integral to understanding the effect on the swallow and the subsequent treatment options available. There is also the risk of post-surgical reduction of physiological reserve, which can reduce the strength and function of the swallow in addition to any surgery specific complications. As lung cancer has a limited prognosis, the clinician must also factor in the palliative phase, as this can further increase the burden of an already compromised swallow. By understanding the surgery and the implications this may have for the swallow, there is the potential to reduce the impact of post-surgical complications and so improve quality of life (QOL) for people with lung cancer.


Sign in / Sign up

Export Citation Format

Share Document